Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 15/20 | 0.53 |
| ▸ | SLC6A9 | P48067 | 4/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20155682 | 0.81 | BRD4 (0.59) | BRD4SLC6A9 | |
| SCHEMBL20160101 | 0.80 | BRD4 (0.55) | BRD4SLC6A9 | |
| SCHEMBL16650725 | 0.80 | BRD4 (0.55) | BRD4SLC6A9 | |
| SCHEMBL2824930 | 0.80 | SLC6A9 (0.59) | BRD4SLC6A9KCNH2 | |
| SCHEMBL15068105 | 0.77 | HTR2A (0.50) | BRD4 | |
| SCHEMBL14059596 | 0.76 | SMN1; SMN2 (0.61) | KCNH2 | |
| SCHEMBL1813202 | 0.75 | SLC6A9 (0.54) | BRD4SLC6A9KCNH2 | |
| SCHEMBL5041633 | 0.73 | SLC6A9 (0.78) | SLC6A9KCNH2 | |
| SCHEMBL2828648 | 0.73 | SLC6A9 (0.53) | BRD4SLC6A9KCNH2 | |
| SCHEMBL29953902 | 0.72 | PTGDR2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128975-A1 | PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR | CELGENE QUANTICEL RESEARCH, INC. (US) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128975-A1 | PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR | BRD1, BRD4, BRD3 | BRD4 2/4885SLC6A9 4633/4885KCNH2 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.